Health Insurer May Not Raise Defense Of Fraud Based On Statements Insureds Made In An Application When The Application Had Been Neither Attached To, Nor Endorsed On, The Policy When Issued.
The California Court of Appeal reversed and remanded a trial court’s denial of class certification for a plaintiff’s Unfair Competition Law (“UCL”) complaint. The Court of Appeal ruled that equitable defenses cannot be used to defeat a UCL cause of action, and that an insurer may not raise the defense of fraud based on statements that insureds made in an application for insurance where the application had been neither attached to, nor endorsed on, the policy when issued.
Read the complete article by clicking on the link below.
Author(s)
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.